Evaluation of the Titan 3-D™ Wedge System

Flat Foot Clinical Trial

Official title:

A Multicenter, Prospective, Post-Market Clinical Follow-Up Evaluation of the Titan 3-D™ Wedge System

Clinical Trial Details — Status: Withdrawn

Administrative data

• NCT number: NCT03421665
• Other study ID #: P03-SP-0001
• Status: Withdrawn
• Start date: June 15, 2018
• Est. completion date: September 1, 2022

Study information

• Verified date: October 2018
• Source: Paragon 28
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

Evaluate clinical healing and radiographic maintenance of correction following an LCL procedure or medial cuneiform osteotomy (Cotton) at 6 months following the use of the TITAN 3-D™ Wedge. Subjects who receive one or more TITAN 3-D™ Wedges will obtain satisfactory levels of clinical healing and radiographic maintenance of correction at 6 months.

Recruitment information / eligibility

• Status: Withdrawn
• Enrollment: 0
• Est. completion date: September 1, 2022
• Est. primary completion date: September 1, 2022
• Accepts healthy volunteers: No
• Gender: All
• Age group: N/A and older

Eligibility

Inclusion Criteria:

1. The subject has foot pain/discomfort on the foot in question.

2. The subject has activity limitations due to the foot in question.

3. The subject agrees to comply with the requirements of the study and complete the study measures.

4. The subject (or representative of the subject in the case of a minor) is willing and able to provide written informed consent.

5. The subject plans on undergoing an LCL procedure and/or medial cuneiform osteotomy with a TITAN 3-D™ Wedge.

Exclusion Criteria:

1. The subject is pregnant.

2. The subject had been previously sensitized to titanium.

3. The subject is scheduled for a same day bilateral LCL procedure or medial cuneiform osteotomy procedure.

4. The subject is not expected to complete the study according to the investigation plan.

5. The subject has been deemed physiologically or psychologically inadequate by the enrolling physician.

6. The subject is: a prisoner, unable to understand what participation in the study entails, mentally incompetent, a known abuser of alcohol and/or drugs or anticipated to be non-compliant.

Related Conditions & MeSH terms

• Flat Foot
• Flatfoot
• Lateral Column Lengthening
• Medial Cuneiform Osteotomy

Intervention

Device:
• Titan 3D Wedge System
Each subject will undergo an LCL procedure and/or medial cuneiform osteotomy with one or more TITAN 3-D™ Wedges. Ancillary fixation should be used in conjunction with each TITAN 3-D™ Wedge used. This surgical procedure will be performed as standard of care and is not part of the research procedures. Post-operative care and weight-bearing/activity restrictions will be at the discretion of the surgeon as part of their standard of care for the procedure.

Locations

Country	Name	City	State
n/a

Sponsors (1)

Lead Sponsor	Collaborator
Paragon 28

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Clinical Healing	Evaluate clinical healing following an LCL procedure or medial cuneiform osteotomy (Cotton) at 6 months following the use of the TITAN 3-D™ Wedge. Clinical healing is defined as lack of pain over the osteotomy site.	6 Months
Primary	Radiographic Maintenance of Correction	Evaluate radiographic maintenance of correction following an LCL procedure or medial cuneiform osteotomy (Cotton) at 6 months following the use of the TITAN 3-D™ Wedge. Radiographic maintenance of correction is defined as the absence of a clinically relevant change in radiographic measures across post-operative time points.	6 Months
Secondary	Time to clinical/radiographic healing (union)	Evaluate time to clinical/radiographic healing (union vs. non-union) after a Titan 3D wedge procedure	24 Months
Secondary	Clinical complications	Complications due to the procedure	24 Months
Secondary	Maintenance of implant position		24 Months
Secondary	Maintenance of anatomical alignment		24 Months
Secondary	Determine bone reaction, if any, to the device such as overgrowth or cystic lesions		24 Months
Secondary	Determine rate of removal of the device and subsequent healing		24 Months
Secondary	Change in anatomical and radiographic angular/positional alignment before and after an LCL procedure and/or medial cuneiform osteotomy using a TITAN 3-D™ Wedge		24 Months
Secondary	Change in VAS Pain Score across multiple time points	Visual Analog Scale (VAS). Line from 0 (no pain) to 10 (worst pain). Patient reported.	Pre-operatively, 2 weeks, 6 weeks, 12 weeks, 6 months, 12 months, 24 months
Secondary	Change in AOFAS Ankle-Hindfoot and/or Midfoot Score across multiple time points	American Orthopaedic Foot and Ankle Society (AOFAS) Ankle-Hindfoot clinical score.; Pain: 0-40 points Function: 0-50 points Alignment: 0-10 points Total Score (sum): 0-100 points (higher score indicates better outcomes); American Orthopaedic Foot and Ankle Society (AOFAS) Midfoot clinical score. Pain: 0-40 points Function: 0-45 points Alignment: 0-15 points Total Score (sum): 0-100 points (higher score indicates better outcomes)	Pre-operatively, 2 weeks, 6 weeks, 12 weeks, 6 months, 12 months, 24 months
Secondary	Change in PROMIS Pain Intensity Score across multiple time points	Patient-Reported Outcomes Measurement Information System (PROMIS) Pain Intensity Score, Item Bank v1.0, SF 3a.; Raw Score Range: 3 (no pain) to 15 (very severe pain)	Pre-operatively, 2 weeks, 6 weeks, 12 weeks, 6 months, 12 months, 24 months
Secondary	Change in PROMIS Mobility Score across multiple time points	Patient-Reported Outcomes Measurement Information System (PROMIS) Mobility Score, Item Bank v2.0.; Raw Score Range: 15 (high level of difficulty) to 120 (no difficulty)	Pre-operatively, 2 weeks, 6 weeks, 12 weeks, 6 months, 12 months, 24 months
Secondary	Change in PROMIS Pain Interference Score across multiple time points	Patient-Reported Outcomes Measurement Information System (PROMIS) Pain Interference Score, Item Bank v1.0, SF 6a.; Raw Score Range: 6 (no interference) to 30 (high level of interference)	Pre-operatively, 2 weeks, 6 weeks, 12 weeks, 6 months, 12 months, 24 months
Secondary	Compare the outcomes and complication rates of TITAN 3-D™ Wedges with previously published outcomes of historical controls, allograft bone and autograft bone		24 Months